Delivery Order SPE2DB22D1106-SPE2DB24FFFM8

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 100 mg tablets. The contract has a ceiling value of $2,544.90 and a completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 150 MG TABLET 60S. The contract has a ceiling value of $1,792.52 and a completion date of September 24, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently procure a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 50 MG TABLET 60S. The contract is a firm fixed-price, delivery order contract with a ceiling value of $5,671.18 and an ultimate completion date of October 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply NUCYNTA ER 100 MG TABLET 60S. The contract is a firm fixed-price delivery order with a ceiling value of $2,777.96 and a period of performance through July 25, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 200 MG TABLET 60S. The award has a ceiling value of $6,053.44 and an ultimate completion date of August 19, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,194.33, is for the delivery of NUCYNTA ER 50 MG TABLET 60S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 250 MG TABLET 60S. The contract has a ceiling value of $8,370.02 and a completion date of June 20, 2024. It is a firm fixed-price contract, and there is no set-aside designation noted. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NUCYNTA ER 100 MG TABLET 60S, a prescription medication, with a ceiling value of $1,134.13 and a completion date of May 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NUCYNTA ER 100 MG TABLET 60S, a prescription medication. The contract has a ceiling value of $2,944.08 and an ultimate completion date of April 15, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 50 MG TABLET 60S. The contract has a ceiling value of $2,193.62 and is a firm fixed-price delivery order type, with a period of performance through May 5, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFFM8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 100 MG TABLET 60S. The contract has a ceiling value of $1,388.98 and runs through August 6, 2024. This order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/4/24, 9:14 AM